Protein kinases as drug targets / (Record no. 11111)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04586cam a2200745Ka 4500 |
| 001 - CONTROL NUMBER | |
| control field | ocn729724693 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20171224113643.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cn||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 110609s2011 gw a ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DG1 |
| Language of cataloging | eng |
| Description conventions | pn |
| Transcribing agency | DG1 |
| Modifying agency | YDXCP |
| -- | N$T |
| -- | CDX |
| -- | OCLCQ |
| -- | OCLCO |
| -- | OCLCQ |
| -- | UWO |
| -- | OCLCQ |
| -- | OCLCA |
| -- | NLGGC |
| -- | IDEBK |
| -- | OCLCQ |
| -- | DEBBG |
| 019 ## - | |
| -- | 756898492 |
| -- | 757403635 |
| -- | 759006763 |
| -- | 816865413 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783527633470 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 3527633472 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9783527633487 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 3527633480 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1283283247 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781283283243 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 9783527317905 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 3527317902 |
| 024 8# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 9786613283245 |
| 029 1# - (OCLC) | |
| OCLC library identifier | AU@ |
| System control number | 000049641601 |
| 029 1# - (OCLC) | |
| OCLC library identifier | GBVCP |
| System control number | 790033518 |
| 029 1# - (OCLC) | |
| OCLC library identifier | NZ1 |
| System control number | 15916500 |
| 029 1# - (OCLC) | |
| OCLC library identifier | DEBBG |
| System control number | BV043393179 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)729724693 |
| Canceled/invalid control number | (OCoLC)756898492 |
| -- | (OCoLC)757403635 |
| -- | (OCoLC)759006763 |
| -- | (OCoLC)816865413 |
| 037 ## - SOURCE OF ACQUISITION | |
| Stock number | 10.1002/9783527633470 |
| Source of stock number/acquisition | Wiley InterScience |
| Note | http://www3.interscience.wiley.com |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM666.E548 |
| Item number | P76 2011 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | W1 |
| Item number | ME9613H v.49 2011 |
| 060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER | |
| Classification number | QU 143 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 071000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | TDCW |
| Source | bicssc |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.798 |
| Edition number | 22 |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | MAIN |
| 245 00 - TITLE STATEMENT | |
| Title | Protein kinases as drug targets / |
| Statement of responsibility, etc | edited by Bert Klebl, Gerhard Müller, and Michael Hamacher. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Weinheim : |
| Name of publisher, distributor, etc | Wiley-VCH ; |
| Place of publication, distribution, etc | Chichester : |
| Name of publisher, distributor, etc | John Wiley [distributor], |
| Date of publication, distribution, etc | ©2011. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource (xxi, 373 pages) : |
| Other physical details | illustrations (some color). |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 490 1# - SERIES STATEMENT | |
| Series statement | Methods and principles in medicinal chemistry ; |
| Volume number/sequential designation | 49 |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc | Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | In vitro characterization of small-molecule kinase inhibitors -- Screening for kinase inhibitors: from biochemical to cellular assays -- Dissecting phosphorylation networks: the use of analogue-sensitive kinases and more specific kinase inhibitors as tools -- Rational drug design of kinase inhibitors for signal transduction therapy -- Kinaes inhibitors in signal transduction therapy -- Design principles of deep pocket-targeting protein kinase inhibitors -- From discovery to clinic: aurora kinase inhibitors as novel treatments for cancer -- Discovery and design of protein kinase inhibitors: targeting the cell cycle in oncology -- Medicinal chemistry approaches for the inhibition of the p38 MAPK pathway -- Cellular protein kinases as antiviral targets -- Prospects for TB therapeutics targeting mycobacterium tuberculosis phosphosignaling networks. |
| 588 0# - | |
| -- | Print version record. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | With Kinase inhibitors being widely seen as the long-sought 'magic bullet' to conquer cancer, this fully comprehensive guide to kinase inhibitor drug development covers the entire drug pipeline from target identification to compound development and clinical application. Volume 1 focuses upon the medicinal chemistry of kinase drugs, from target identification to lead optimization, and contains numerous contributions from large and small pharmaceutical companies. Volume 2 surveys current and future therapeutic application areas for kinase inhibitor drugs, with a strong focus on oncology drugs, as this is the most important therapeutic field for these drugs. In addition, all six currently approved kinase inhibitor drugs (small molecules and antibodies) are described, and their performances in clinical practice are discussed. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Protein kinases |
| General subdivision | Inhibitors. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Antineoplastic agents |
| General subdivision | Development. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Protein Kinase Inhibitors |
| General subdivision | therapeutic use. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug Delivery Systems. |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug Discovery. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL |
| General subdivision | Pharmacology. |
| Source of heading or term | bisacsh |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Müller, Gerhard. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Klebl, Bert. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | Wiley InterScience (Online service) |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Print version: |
| Title | Protein kinases as drug targets. |
| Place, publisher, and date of publication | Weinheim : Wiley-VCH ; Chichester : John Wiley [distributor], ©2011 |
| International Standard Book Number | 9783527317905 |
| Record control number | (OCoLC)664325820 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Methods and principles in medicinal chemistry ; |
| Volume number/sequential designation | 49. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://onlinelibrary.wiley.com/book/10.1002/9783527633470">http://onlinelibrary.wiley.com/book/10.1002/9783527633470</a> |
| Public note | Wiley Online Library |
| 938 ## - | |
| -- | Coutts Information Services |
| -- | COUT |
| -- | 19349327 |
| 938 ## - | |
| -- | EBSCOhost |
| -- | EBSC |
| -- | 398561 |
| 938 ## - | |
| -- | Ingram Digital eBook Collection |
| -- | IDEB |
| -- | 328324 |
| 938 ## - | |
| -- | YBP Library Services |
| -- | YANK |
| -- | 7191904 |
| 994 ## - | |
| -- | 92 |
| -- | DG1 |
No items available.